JPH10506632A - 慢性関節リウマチを治療するためのメトトレキセートとテニダップとの組合せ物 - Google Patents

慢性関節リウマチを治療するためのメトトレキセートとテニダップとの組合せ物

Info

Publication number
JPH10506632A
JPH10506632A JP8521896A JP52189696A JPH10506632A JP H10506632 A JPH10506632 A JP H10506632A JP 8521896 A JP8521896 A JP 8521896A JP 52189696 A JP52189696 A JP 52189696A JP H10506632 A JPH10506632 A JP H10506632A
Authority
JP
Japan
Prior art keywords
tenidap
methotrexate
treatment
dose
patients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8521896A
Other languages
English (en)
Japanese (ja)
Inventor
リットマン，ブルース・エイチ
Original Assignee
ファイザー・インコーポレーテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ファイザー・インコーポレーテッド filed Critical ファイザー・インコーポレーテッド
Publication of JPH10506632A publication Critical patent/JPH10506632A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP8521896A 1995-05-10 1995-05-10 慢性関節リウマチを治療するためのメトトレキセートとテニダップとの組合せ物 Pending JPH10506632A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1995/000343 WO1996035419A1 (en) 1995-05-10 1995-05-10 Combination of methotrexate and tenidap for the treatment of rheumatoid arthritis

Publications (1)

Publication Number Publication Date
JPH10506632A true JPH10506632A (ja) 1998-06-30

Family

ID=11004328

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8521896A Pending JPH10506632A (ja) 1995-05-10 1995-05-10 慢性関節リウマチを治療するためのメトトレキセートとテニダップとの組合せ物

Country Status (5)

Country Link
EP (1) EP0827404A1 (es)
JP (1) JPH10506632A (es)
FI (1) FI974171A0 (es)
MX (1) MX9708620A (es)
WO (1) WO1996035419A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1276031B1 (it) * 1995-10-31 1997-10-24 Angelini Ricerche Spa Composizione farmaceutica per il trattamento delle malattie autoimmuni
EP1019064A4 (en) 1997-02-28 2006-11-08 Univ California INHIBITION OF CELL-CELL BINDINGS BY LIPID COMPOSITIONS
WO1999062525A1 (en) * 1998-06-05 1999-12-09 Supergen, Inc. Compositions comprising methotrexate and pentostatin for treating rheumatoid arthritis
EP3755324A1 (en) 2018-02-20 2020-12-30 Agios Pharmaceuticals, Inc. Methods of use for trisubstituted benzotriazole derivatives

Also Published As

Publication number Publication date
WO1996035419A1 (en) 1996-11-14
MX9708620A (es) 1998-02-28
FI974171A (fi) 1997-11-07
EP0827404A1 (en) 1998-03-11
FI974171A0 (fi) 1997-11-07

Similar Documents

Publication Publication Date Title
Jordon et al. Bullous pemphigoid associated with systemic lupus erythematosus
JP2021181501A (ja) 免疫不全疾患を処置するための方法
JP3838065B2 (ja) 肺高血圧の治療剤
AU2011279144A1 (en) Methods of treating hepatorenal syndrome and hepatic encephalopathy with thromboxane-A2 receptor antagonists
JP2022525759A (ja) ピリダジノンｔｒｐｃ阻害剤の結晶形態
Hochster et al. Effect of prolonged topotecan infusion on topoisomerase 1 levels: a phase I and pharmacodynamic study.
JPH10506632A (ja) 慢性関節リウマチを治療するためのメトトレキセートとテニダップとの組合せ物
JP2013545759A (ja) 低酸素状態に基づくエレスクロモールによる治療に適した被験体の事前選択
US20220370467A1 (en) Using of a ppar-delta agonist in the treatment of kidney disease
Wanchu et al. Elevated nitric oxide production in patients with primary Sjögren’s syndrome
Gärtner et al. Comparison of clinical and morphological features of peri-(epi-extra) membranous glomerulonephritis
JP2023501317A (ja) Ｂ細胞悪性腫瘍を処置するためのアカラブルチニブとカピバセルチブとの治療的組み合わせ
US11541030B2 (en) Methods for the treatment of inflammation associated with infection
JPH11507012A (ja) 心臓血管系病気の処置におけるアンギオテンシン変換酵素阻害薬と副作用軽減量のアルドステロン拮抗薬との組合わせ治療
US5750495A (en) Treatment of cystic disease with TNF-α
CN115551509A (zh) 包含craf抑制剂的治疗组合
MXPA97008620A (es) Combinacion de metotrexate y tenidap para el tratamiento de artritis reumatoide
Day et al. Induction of salicyluric acid formation in rheumatoid arthritis patients treated with salicylates
WO2021195698A1 (en) Methods for the treatment of inflammation associated with infection
Kajander et al. Prolonged treatment with tolfenamic acid in inflammatory rheumatic diseases
WO2019032672A1 (en) METHOD OF TREATING SCHNITZLER SYNDROME
RU2772693C1 (ru) Твердые дисперсии и фармацевтические композиции, включающие замещенный индан, и способы их приготовления и применения
CA2219397A1 (en) Combination of methotrexate and tenidap for the treatment of rheumatoid arthritis
TW202210068A (zh) 用於治療家族性地中海型發熱病的cxcr-2抑制劑
US20080312250A1 (en) Combination Comprising a Bcrp Inhibitor and 4- (4-Methylpiperazin-1-Ylmethyl)-N-[4-Methyl-3- (4-Pyridin-3-Yl) Pyrimidin-2-Ylamino) Phenyl] -Benzamide